Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bened Biomedical (also known as Yifu Biomedical) is a Taiwan-based biotechnology company specializing in the development of psychobiotics—probiotics that influence the gut-brain axis to improve mental and neurological health. The company's lead product, Lactobacillus plantarum PS128, has been clinically studied for its effects on Parkinson's disease, autism spectrum disorder, and depression. Bened Biomedical leverages its proprietary microbiome research to develop live biotherapeutic products and functional food supplements. The company operates globally, providing evidence-based microbial solutions for neurological and psychiatric conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yifu Biomedical.